Pfizer's Prevnar to be Considered Effective and Safe - FDA
The US Food and Drug Administration on Wednesday, after a round of voting, announced that the new version of children's medicine Prevnar should be considered both effective and safe for administration...
View ArticlePfizer Units to Pay over $165 Million in Damages over Menopause Medicine
A jury orders has asked Wyeth and Pharmacia & Upjohn Pfizer units to pay over $165 Million in damages to women who contacted cancer after long terms use of the drug manufacturer's Prempro...
View ArticleU.S. FDA Still Not Satisfied of Pfizer vaccine
The U. S. Food and Drug Administration have still not given a green signal to Prevnar vaccine of Pfizer. This children’s vaccine has been developed to fight pneumonia and meningitis, but it seems that...
View ArticleAuxilium to Start Review of Pfizer Drug Xiaflex
In what would come as welcome news to patients suffering from Dupuytren's Contracture, Pfizer Inc. and Auxilium Pharmaceutical Inc. have announced that the scientific/technical review procedure of the...
View ArticleBillions are Spent on Fake Medicines by Europeans
According to a Pfizer-sponsored survey, western Europeans spend an estimated 10.5 billion Euros on counterfeit medicines in a year. These medicines contain the wrong or even toxic ingredients that...
View ArticleCancer Drug Mylotarg to Be Withdrawn by Pfizer
The Food and Drug Administration said on Monday that Pfizer Inc. is withdrawing its cancer drug Mylotarg from the U. S. market after a clinical trial depicted that the drug wasn't effectual and had...
View ArticlePfizer Linked With Health Issues
A novel study conducted by German researchers unveiled Wednesday claimed the Pfizer's antidepressant reboxetine as completely ineffective and detrimental for the patient. It highlighted that the health...
View ArticlePfizer Linked With Health Issues
A novel study conducted by German researchers unveiled Wednesday claimed the Pfizer's antidepressant reboxetine as completely ineffective and detrimental for the patient. It highlighted that the health...
View ArticleNon-prescription Drugs no Cure for Chronic Pain
In line with the Asian Pacific Digestive Week , a survey, initiated by the biopharmaceutical firm Pfizer and conducted in China, Taiwan and Thailand, shows that patients that suffer from chronic pain...
View ArticlePfizer Makes Another Recall
Pfizer is reported to have widened the voluntary recall of its blockbuster cholesterol-fighting drug again. As per the company’s statement, an additional 38,000 bottles of the drug Lipitor have been...
View Article3 in 10 Asians Prone to Overactive Bladder
On the basis of a research conducted by Pfizer, 59% of people suffered from the symptoms of overactive bladder (OAB).The study found that three in 10 Asians are prone to overactive bladder (OAB), a...
View ArticleSpin-offs might possible show a ray of hope for Pfizer site
With the US maker Pfizer announcing the shutdown of its research and development site at Sandwich in Kent, the decision came as a blow this week as around 2,400 jobs are at risk.The site, which has had...
View ArticlePfizer interested in AstraZeneca: report
American pharmaceuticals giant Pfizer Inc is reportedly mulling a plan to place a bid for struggling British drugs-maker AstraZeneca.While Pfizer hasn't revealed any such plan so far, London's Sunday...
View ArticleAstraZeneca’s potential takeover by Pfizer may lead to thousands of job cuts
The potential takeover of British pharmaceuticals firm AstraZeneca by American drugs giant Pfizer has raised concerns about the future of British firm's employees.Pfizer, well-known for its erectile...
View ArticleBritish lawmakers anxiously watching Pfizer-AstraZeneca talks
British lawmakers are concerned about the future of AstraZeneca and thousands of its employees, as U. S.-based pharmaceuticals giant Pfizer is preparing a £60 billion (nearly $100bn) takeover bid for...
View ArticleTwo state leaders express concerns over Pfizer’s potential takeover of...
Governors of Delaware and Maryland have expressed their concerns over the impact of Pfizer Inc.'s proposed takeover of British pharmaceuticals giant AstraZeneca on workers as well as the states'...
View ArticleAstraZeneca is apparently not British
Amid ongoing political storm over Pfizer's potential takeover of British pharmaceuticals giant AstraZeneca, some analysts have pointed out that AstraZeneca is apparently not British.AstraZeneca is a...
View ArticlePfizer promises to keep British research jobs in the country
Pfizer Inc.'s chief executive Ian Read on Tuesday acknowledged that a potential takeover of AstraZeneca would lead to job losses, but it assured that the company's British research jobs would be kept...
View ArticlePfizer-AstraZeneca deal is not inevitable: Pascal Soriot
Pfizer's takeover bid for AstraZeneca is not inevitable and the Anglo-Swedish pharmaceutical giant can create value for its shareholder on its own, according to AstraZeneca CEO Pascal Soriot's claims....
View ArticlePfizer raises its ‘final’ bid for AstraZeneca to £69bn
Pfizer CEO Ian Read on Sunday described the company's new proposal for AstraZeneca as "compelling" and cautioned that the American drugmaker would walk away if AstraZeneca didn't accept it.The U....
View Article
